BioAge Labs, Inc. (BIOA)
About BioAge Labs, Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $9.0M
- Net income
- -$80.6M
- Total assets
- $294.9M
- Market cap
- $697.9M
- Operating margin
- -1031.5%
- Net margin
- -896.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $9.0M
- Operating expenses
- $101.8M
- Operating income
- -$92.8M
- Income tax
- $0
- Net income
- -$80.6M
- EPS (basic)
- $-2.24
- EPS (diluted)
- $-2.24
Balance sheet
- Total assets
- $294.9M
- Current assets
- $286.8M
- Total liabilities
- $22.8M
- Current liabilities
- $20.1M
- Shareholders’ equity
- $272.1M
Cash flow
- Operating cash flow
- -$81.6M
- Investing cash flow
- -$95.2M
- Financing cash flow
- $11.5M
- Net cash flow
- -$165.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $697.9M
- EPS (diluted)
- $-2.24
- Shares outstanding
- 32.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 26, 2024
BioAge Labs, Inc. (BIOA) Stock Price
- Reported a net loss of $80.6M in FY2025.
- Revenue grew 314% from FY2015 to FY2025.
- Trading 13% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BioAge Labs, Inc..
Write a review
News about BioAge Labs, Inc.
News & sentiment via Polygon.io
BioAge Labs, Inc.: frequently asked questions
Is BioAge Labs, Inc. an American company?
BioAge Labs, Inc. is a US-based company headquartered in Emeryville, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BioAge Labs, Inc. headquartered?
BioAge Labs, Inc. is headquartered in Emeryville, California, United States.
Is BioAge Labs, Inc. publicly traded?
Yes — BioAge Labs, Inc. is a publicly traded company. Its stock trades under the ticker symbol BIOA on the NASDAQ.
What does BioAge Labs, Inc. do?
BioAge Labs, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
